Efficacy of rFIXFc versus rIX-FP for the Treatment of Patients with Hemophilia B: Matching-Adjusted Indirect Comparison of B-LONG and PROLONG-9FP Trials
Jan Astermark,1 Piotr Wojciechowski,2 Samuel Aballéa,3 Zalmai Hakimi,4 Jameel Nazir,4 Robert Klamroth5 1Department of Translational Medicine, Lund University, and Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Malmö, Sweden; 2Creativ-Ceutical, Krakow, Poland; 3C...
Main Authors: | Astermark J, Wojciechowski P, Aballéa S, Hakimi Z, Nazir J, Klamroth R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-07-01
|
Series: | Journal of Blood Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-of-rfixfc-versus-rix-fp-for-the-treatment-of-patients-with-he-peer-reviewed-fulltext-article-JBM |
Similar Items
-
Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease
by: Rita C. Santoro, et al.
Published: (2021-09-01) -
New developments in the management of moderate-to-severe hemophilia B
by: Nazeef M, et al.
Published: (2016-04-01) -
The odds and implications of coinheritance of hemophilia A and B
by: Corinne Karch, et al.
Published: (2020-07-01) -
Clinical utility and patient perspectives on the use of extended half-life rFIXFc in the management of hemophilia B
by: Miguelino MG, et al.
Published: (2014-08-01) -
Genetic variation of rs438601 marker in the Iranian Population: An informative marker for molecular diagnosis of hemophilia B
by: P Dorri, et al.
Published: (2014-12-01)